Harvard Bioscience (HBIO) Total Liabilities (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Total Liabilities of $67.9 million for Q1 2026, up 4.5% year-over-year from $65.0 million in Q1 2025, and up 2.34% quarter-over-quarter from $66.3 million in Q4 2025.
Harvard Bioscience (HBIO) Total Liabilities (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Total Liabilities for 17 consecutive years, with $67.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities rose 4.5% year-over-year to $67.9 million; the TTM figure through Mar 2026 stood at $67.9 million (up 4.5% YoY), while the FY2025 annual figure was $66.3 million, up 4.79% from the prior year.
- Total Liabilities advanced to $67.9 million in Q1 2026 per HBIO's latest filing, from $66.3 million in the prior quarter.
- Across five years, Total Liabilities topped out at $81.7 million in Q1 2022 and bottomed at $61.7 million in Q2 2024.
- Historically, Total Liabilities has averaged $68.2 million across 5 years, with a median of $65.9 million in 2024.
- Annual changes were most pronounced in 2022 — Total Liabilities grew 10.16% — and 2023, when it retreated 13.19%.
- Harvard Bioscience's Total Liabilities stood at $73.1 million in 2022, then retreated by 12.1% to $64.3 million in 2023, then dropped by 1.54% to $63.3 million in 2024, then advanced by 4.79% to $66.3 million in 2025, then advanced by 2.34% to $67.9 million in 2026.
- Business Quant data shows HBIO's Total Liabilities at $67.9 million in Q1 2026, $66.3 million in Q4 2025, and $63.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 2.58 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 50.73 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 9.50 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 2.38 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 20.27 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 1.09 Bn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 9.44 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 4.24 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 13.61 Bn |
| 10 | Harvard Bioscience | 34.12 Mn | 27.61 Mn | 12.63 Mn | 68.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 68.87 Mn |
| Mar 31, 2026 | 67.89 Mn |
| Dec 31, 2025 | 66.34 Mn |
| Sep 30, 2025 | 63.92 Mn |
| Jun 30, 2025 | 64.36 Mn |
| Mar 31, 2025 | 64.97 Mn |
| Dec 31, 2024 | 63.30 Mn |
| Sep 30, 2024 | 65.92 Mn |
| Jun 30, 2024 | 61.67 Mn |
| Mar 31, 2024 | 64.35 Mn |
| Dec 31, 2023 | 64.29 Mn |
| Sep 30, 2023 | 65.45 Mn |
| Jun 30, 2023 | 67.51 Mn |
| Mar 31, 2023 | 71.24 Mn |
| Dec 31, 2022 | 73.14 Mn |
| Sep 30, 2022 | 75.03 Mn |
| Jun 30, 2022 | 77.77 Mn |
| Mar 31, 2022 | 81.67 Mn |
| Dec 31, 2021 | 78.94 Mn |
| Sep 30, 2021 | 76.99 Mn |